We also report on a potentially simple solution to nausea experienced by cancer patients receiving morphine for pain.
We also report on potentially important discoveries that could lead to the first treatment for West Nile virus, and improved care of pneumonia patients.
Practical takeaways from new NCCN guidance
We also report on new understanding of how Ebola infections may persist in the brain and other organs for months, and a troubling spread of drug-resistant bacteria outside of the hospital setting.
We also highlight some potentially good news for people suffering knee arthritis pain, a treatment that can help delay or avoid replacement surgery.
VTE models, ADAPT-BLEED, and DOAC vs warfarin
Treatment choices across breast cancer stages
MRI, PET–CT, and radiotherapy decisions
Genetics, fertility, and survivorship insights
We also report on a finding that could reverse current concussion guidance for kids.
We also report on promising early data that could produce a better option for treating C. difficile-caused diarrhea, and the first vaccine for preventing Lassa fever.
Rapid, deep responses in early-phase study
κ subgroup benefit observed in CARES trial
Risk stratification using TILs, ctDNA, genomics
We also highlight a series of promising CAR-T studies in a variety of hard-to-treat rheumatology disorders.
Today we revisit the American Society of Clinical Oncology scientific meeting in Chicago, which concluded on Tuesday, to report on three more potentially practice-changing studies.
Phase 3 EA5142 results presented at ASCO 2026
POTOMAC shows stable OS and QoL
HARMONi-6 shows OS benefit vs PD-1
PROTEUS shows improved MFS outcomes
